Mercado cuantitativo de relaciones estructura-actividad: mapeo competitivo y perspectivas estratégicas 2031

  • Report Code : TIPRE00018665
  • Category : Healthcare IT
  • Status : Published
  • No. of Pages : 148
Buy Now

Se espera que el mercado de la relación cuantitativa estructura-actividad (QSAR) alcance los 1.888,5 millones de dólares en 2027, desde los 1.388,1 millones de dólares de 2019; se estima que crecerá a una tasa compuesta anual del 4,0% de 2020 a 2027.

El crecimiento del mercado se atribuye principalmente a la creciente tasa de adopción de herramientas de modelado en el descubrimiento de fármacos y al aumento económico del descubrimiento de fármacos. Sin embargo, la baja tasa de adopción de la técnica en los países emergentes está obstaculizando el crecimiento del mercado de la relación cuantitativa estructura-actividad.

Regiones lucrativas para el mercado de la relación cuantitativa estructura-actividad


Perspectivas del mercado

Adopción creciente de herramientas de modelado en el descubrimiento de fármacos

QSAR es un método de modelado computacional utilizado para determinar las relaciones entre las propiedades estructurales y actividades biológicas de compuestos químicos. El descubrimiento y desarrollo de fármacos, junto con el estudio de las posibles aplicaciones terapéuticas del fármaco, es un proceso complicado, costoso y que requiere mucho tiempo. Las empresas farmacéuticas y biofarmacéuticas están adoptando diversas metodologías computacionales como QSAR para aumentar la eficiencia de todo este proceso. En etapas que van desde la identificación de resultados hasta la optimización de clientes potenciales, varias compañías farmacéuticas están utilizando ampliamente técnicas como la detección virtual basada en ligandos o estructuras. Con la ayuda del modelado, se pueden aprovechar los datos existentes para obtener información sobre la seguridad y eficacia del producto. Debido a la eficiencia de los métodos computacionales, la Administración de Medicamentos y Alimentos (FDA) y la Agencia Europea de Medicamentos (EMA)han incorporado modelos de fármacos para lograr resultados eficientes. desarrollo de fármacos. Además, se están utilizando diseños in silico (asistidos por computadora) para acelerar y realizar el proceso de identificación de resultados; optimizar la distribución, absorción y metabolismo de compuestos; y dibujar un perfil de toxicidad para evitar problemas de seguridad. Los enfoques in silico comúnmente utilizados incluyen el diseño de fármacos basado en estructuras basadas en ligandos, el diseño de fármacos y las relaciones cuantitativas estructura-actividad. Como estos métodos son más rápidos y proporcionan información valiosa sobre los hallazgos experimentales y los mecanismos de acción, varias compañías farmacéuticas han comenzado a adoptar estas técnicas para obtener mejores resultados, lo que está impulsando el crecimiento del mercado de la relación cuantitativa estructura-actividad.

Información basada en aplicaciones

El mercado de la relación cuantitativa estructura-actividad (QSAR), basado en la aplicación, se segmenta en descubrimiento de fármacos, modelado molecular, detección química, regulación y toma de decisiones. y otras aplicaciones. En 2019, el segmento de descubrimiento de fármacos tuvo la mayor participación del mercado y, además, se espera que registre la CAGR más alta del mercado durante el período de pronóstico. El crecimiento del mercado para este segmento se atribuye principalmente a la creciente tasa de adopción de tecnologías en el proceso de descubrimiento de fármacos.

Mercado cuantitativo de la relación estructura-actividad, por aplicación: 2019 y 2027

Perspectivas basadas en la industria

El mercado de relaciones cuantitativas estructura-actividad, por industria, se segmenta en productos farmacéuticos, cosméticos, ambientales y alimentarios y bebidas. En 2019, el segmento farmacéutico tuvo la mayor participación del mercado y se espera que el mismo segmento registre la CAGR más alta del mercado durante 2020-2027.

Estratégico Insights

Algunos actores que operan en el mercado de relaciones cuantitativas estructura-actividad son Protoqsar Sl., Intertek Group Plc, Bibra Toxicology Advice And Consulting Ltd, Covance Inc. (Labcorp), Latham Biopharm Group, Nsf International, Biolabs creativos, Qsar Lab Sp. z o.o. ZO y Dassault Systèmes. Estos actores están adoptando varias estrategias orgánicas e inorgánicas para mejorar sus ingresos y su posición en el mercado. Por ejemplo, en mayo de 2019, Dassault Systems adquirió Medidata Solution para obtener acceso a su experiencia clínica y agregar sus soluciones basadas en la nube al portafolio de Dassault.

Estructura cuantitativa -Mercado de relaciones de actividades: por aplicación

  • Descubrimiento de fármacos
  • Modelado molecular
  • Detección química
  • Reglamentación y toma de decisiones
  • Otras aplicaciones

Mercado de relación cuantitativa estructura-actividad: por Industria

  • Farmacéutica
  • Cosmética
  • Medioambiental
  • Alimentos y Bebidas

Mercado cuantitativo de relaciones estructura-actividad: por Geografía

  • América del Norte
    • Estados Unidos
    • Canadá
    • México
  • < li>Europa
    • Francia
    • Alemania
    • Italia
    • Reino Unido
    • España
  • Asia Pacífico (APAC)
    • China
    • India
    • Corea del Sur
    • Japón
    • Australia
  • Medio Oriente y África (MEA)
    • Sudáfrica
    • Arabia Saudita
    • EAU< /li>
  • América del Sur y Central
    • Brasil
    • Argentina
< p> 

Perfiles de empresas

  • Protoqsar Sl.,
  • Intertek Group Plc,
  • Bibra Toxicology Advice And Consulting Ltd,
  • Covance Inc. (Labcorp),
  • Latham Biopharm Grupo,
  • Nsf International,
  • Creative Biolabs,
  • Qsar Lab Sp. ZO,
  • DassaultSystèmes.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is quantitative structure-activity relationship (QSAR)?

A quantitative structure-activity relationship (QSAR) is a computational or mathematical modeling approach to reveal connections between biological activities and chemical compounds' structural properties. It attempts to correlate chemical structure with an activity using statistical approaches. The QSAR models are beneficial for various purposes, including the prediction of actions of untested chemicals. Also, it helps to prioritize desired biological activities as an in silico methodology and thus decreases the number of candidate chemicals to be tested with in vivo experiments.

What are the driving factors for the quantitative structure-activity relationship (QSAR) market across the globe?

Factors such as increasing adoption of modeling tools in drug discovery and increasing economic burden of drug discovery are expected to drive the market growth. However, less adoption in emerging countries hinders the growth of the market.

What is the regional market scenario of quantitative structure-activity relationship (QSAR)?

Global quantitative structure-activity relationship (QSAR) market is segmented by region into North America, Europe, Asia Pacific, Middle East &Africa and South & Central America. The North American region is the largest shareholder and the Asia Pacific is the fastest growing market for quantitative structure-activity relationship (QSAR). The growth of the North America market is attributed to growing adoption ate of the artificial intelligence technologies in the pharmaceutical industries of the region. Additionally, Canada’s Centre for Drug Research and Development has been working to grow and accelerate Canadian-based research, and has spun out seven companies that aim to solve unmet medical needs.

The List of Companies - Global Quantitative Structure-Activity Relationship (QSAR) Market

  1. Protoqsar Sl.
  2. Intertek Group Plc
  3. Bibra Toxicology Advice And Consulting Ltd
  4. Covance Inc. (Labcorp)
  5. Latham Biopharm Group
  6. Nsf International
  7. Creative Biolabs
  8. Qsar Lab Sp. Z O
  9. Dassault Systèmes

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports